SCHEMBL21910046

SCHEMBL21910046

CC(C)(C)OC(=O)N1CC(O)CC(C(F)F)C1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.47
CHRM2 P08172 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
USP2 O75604 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
DPP4 P27487 1/20 0.38
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
RORC P51449 1/20 0.36
HPGD P15428 1/20 0.36
EPHX2 P34913 1/20 0.36
KDM4E B2RXH2 1/20 0.36
RECQL P46063 1/20 0.35
EPHX1 P07099 1/20 0.35
PREP P48147 1/20 0.35
NAMPT P43490 1/20 0.34
USP30 Q70CQ3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10190233 0.87 NR1H2 (0.50) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL25072009 0.84 NR1H2 (0.46) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL9965499 0.84 NR1H2 (0.57) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL22413119 0.84 NR1H2 (0.57) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL31433037 0.84 NR1H2 (0.57) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL16985478 0.84 NR1H2 (0.57) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL22413118 0.84 NR1H2 (0.57) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL29105865 0.84 NR1H2 (0.57) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL26100661 0.81 NR1H2 (0.60) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL21811405 0.81 NR1H2 (0.41) NR1H2CHRM2CHRM1CHRM3USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12071425-B2 Phenoxy-pyridyl-pyrimidine compounds and methods of use GENENTECH, INC. (US) 2024-08-27 US disclosed
US-20230057166-A1 PHENOXY-PYRIDYL-PYRIMIDINE COMPOUNDS AND METHODS OF USE GENENTECH INC (US) 2023-02-23 US disclosed
US-20230057166-A1 PHENOXY-PYRIDYL-PYRIMIDINE COMPOUNDS AND METHODS OF USE GENENTECH INC (US) 2023-02-23 US disclosed
CN-112739420-A Phenoxy-pyridyl-pyrimidine compounds and methods of use 基因泰克公司 2021-04-30 CN disclosed
WO-2020056089-A1 PHENOXY-PYRIDYL-PYRIMIDINE COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2020-03-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230057166-A1 PHENOXY-PYRIDYL-PYRIMIDINE COMPOUNDS AND METHODS OF USE XBP1, ERN1, ESR2 NR1H2 146/4885CHRM2 3266/4885CHRM1 2582/4885
US-12071425-B2 Phenoxy-pyridyl-pyrimidine compounds and methods of use XBP1, ERN1, ESR2 NR1H2 146/4885CHRM2 3266/4885CHRM1 2582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.